Brightstar Capital Partners Acquires Analyte Health to Accelerate Direct-to-Consumer Digital Healthcare Growth

What You Should Know: 

– Brightstar Capital Partners (“Brightstar”), a private equity firm, announced it has acquired Analyte Health (“Analyte”), a technology-driven, direct-to-consumer digital health company. 

– As part of the acquisition, Analyte founder Fiyyaz Pirani will continue as CEO and retain a significant ownership stake in the Company. Financial detials of the acquisition were not disclosed.

Direct-to-Consumer Healthcare

Analyte Health provides discreet, high-quality diagnostic and treatment services across key consumer wellness categories. Powered by a proprietary technology stack and a national network of partner laboratories and physicians, Analyte delivers an integrated experience spanning clinical testing, virtual care, and prescription fulfillment. The Company has served millions of patients across the U.S. and continues to expand its offering in wellness, sexual health, and hormonal therapies.

“This partnership marks an exciting new chapter for us, as Brightstar brings both strategic expertise and a deep respect for the culture and customer trust we’ve built,” said Fiyyaz Pirani, CEO of Analyte. “I’m confident Brightstar’s operational resources and investment will help us scale while staying true to our mission of providing accessible, high-quality care directly to the consumer. I’m proud to continue leading the Company forward and remain fully committed as a significant shareholder.”

What You Should Know: 

– Brightstar Capital Partners (“Brightstar”), a private equity firm, announced it has acquired Analyte Health (“Analyte”), a technology-driven, direct-to-consumer digital health company. 

– As part of the acquisition, Analyte founder Fiyyaz Pirani will continue as CEO and retain a significant ownership stake in the Company. Financial detials of the acquisition were not disclosed.

Direct-to-Consumer Healthcare

Analyte Health provides discreet, high-quality diagnostic and treatment services across key consumer wellness categories. Powered by a proprietary technology stack and a national network of partner laboratories and physicians, Analyte delivers an integrated experience spanning clinical testing, virtual care, and prescription fulfillment. The Company has served millions of patients across the U.S. and continues to expand its offering in wellness, sexual health, and hormonal therapies.

“This partnership marks an exciting new chapter for us, as Brightstar brings both strategic expertise and a deep respect for the culture and customer trust we’ve built,” said Fiyyaz Pirani, CEO of Analyte. “I’m confident Brightstar’s operational resources and investment will help us scale while staying true to our mission of providing accessible, high-quality care directly to the consumer. I’m proud to continue leading the Company forward and remain fully committed as a significant shareholder.”